Indications and uses
for preparation of the skin prior to injection helps reduce bacteria that can potentially cause skin infection
for preparation of the skin prior to injection helps reduce bacteria that can potentially cause skin infection
Isopropyl alcohol
Povidone-iodine
Antiseptic
Flammable
For external use only
D o not use on patients with known allergies to iodine or isopropyl alcohol
When using this product keep out of the eyes
Stop use and consult a physician if
Keep out of reach of children. In case of accidental ingestion, seek professional assistance or consult a poison control center immediately.
Directions
For preparation for dry sites such as abdomen, chest or arm
acrylates/steareth-20 methacrylate copolymer, aminomethyl propanol, phosphoric acid, purified water
For questions, comments, or to report serious side effects:
800 760-3236
Monday-Friday
8:30 a.m. - 5:00 p.m. EST
ExCel AP
Povidone-Iodine
Antiseptic
NON-STERILE Solution
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52380-0039-4 | 2020-02-03 | C162847 | 48780-1 | 9d75b9d0-3c94-f424-e053-dadaa90a57ce | 0039 Aplicare ExCel AP |
| 52380-0039-8 | 2020-02-03 | C162847 | 48780-1 | 9d75b9d0-3c94-f424-e053-dadaa90a57ce | 0039 Aplicare ExCel AP |
| 52380-0039-9 | 2020-02-03 | C162847 | 48780-1 | 9d75b9d0-3c94-f424-e053-dadaa90a57ce | 0039 Aplicare ExCel AP |
| 52380-0039-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3c94-f424-e053-dadaa90a57ce | 0039 Aplicare ExCel AP |
| 52380-0039-8 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3c94-f424-e053-dadaa90a57ce | 0039 Aplicare ExCel AP |
| 52380-0039-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3c94-f424-e053-dadaa90a57ce | 0039 Aplicare ExCel AP |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 52380-0039-4 | EA - Each | 52380-0039 | e561d835-62e1-4996-8b35-64d42fdd5535 | 1 | 2012-07-24 |
| 52380-0039-9 | EA - Each | 52380-0039 | 597bfe0a-a888-4628-9535-33476ea71503 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ISOPROPYL ALCOHOL | ACTIVE INGREDIENT | ND2M416302 | 9 | |
| POVIDONE-IODINE | ACTIVE INGREDIENT | 85H0HZU99M | 9 | |
| IODINE | ACTIVE MOIETY | 9679TC07X4 | 9 | |
| ISOPROPYL ALCOHOL | ACTIVE MOIETY | ND2M416302 | 9 | |
| AMINOMETHYLPROPANOL | INACTIVE INGREDIENT | LU49E6626Q | 9 | |
| PHOSPHORIC ACID | INACTIVE INGREDIENT | E4GA8884NN | 9 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 9 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 52380-0039 | 52380-0039-9, 52380-0039-4, 52380-0039-8 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| AMINOMETHYLPROPANOL | LU49E6626Q | IACT |
| PHOSPHORIC ACID | E4GA8884NN | IACT |
| POVIDONE-IODINE | 85H0HZU99M | ACTIM |
| ISOPROPYL ALCOHOL | ND2M416302 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | SPONGE / TOPICAL | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | CREAM / VAGINAL | 0.56 %w/w | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | TABLET, EXTENDED RELEASE / ORAL | 0.19 mg | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | TABLET / ORAL | 0.04 mg | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | SOLUTION / ORAL | 19 mg | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | INJECTION / SOFT TISSUE | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | CREAM / TOPICAL | 13 mg | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | LOTION, AUGMENTED / TOPICAL | 1 mg | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | ADJ PH | ||
| AMINOMETHYLPROPANOL | AMINOMETHYLPROPANOL | LU49E6626Q | LOTION / TOPICAL | 0.3 %w/w | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | GEL / TOPICAL | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | SOLUTION / TOPICAL | 0.23 %w/w | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | PASTE, DENTIFRICE / DENTAL | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | INJECTION, SOLUTION / INTRAVENOUS | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | INJECTION / INTRALESIONAL | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 6 mg | ||
| AMINOMETHYLPROPANOL | AMINOMETHYLPROPANOL | LU49E6626Q | CREAM / TOPICAL | 1 %w/w | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | AEROSOL, FOAM / VAGINAL | NA | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | INJECTION / INTRAMUSCULAR | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | OINTMENT / TOPICAL | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | LOTION / TOPICAL | 1 mg | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | INJECTION / INTRA-ARTICULAR | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | INJECTION / INTRAVENOUS | 1294 mg | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | SOLUTION / OPHTHALMIC | ADJ PH | ||
| PHOSPHORIC ACID | PHOSPHORIC ACID | E4GA8884NN | TABLET, ORALLY DISINTEGRATING / ORAL | 4 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 65a82ddc-80f9-ed37-e053-2a91aa0a62c7 | 76615174-e530-4e88-a02c-2f7d0b5a5b04 | 2018-02-20 | Warnings | 76615174-e530-4e88-a02c-2f7d0b5a5b04 |
Adverse event summaries are temporarily unavailable. Other product information remains available.